An extracellular matrix powder supplier needs about $205k-$249k in monthly revenue to break even under the provided first-year assumptions Here’s the quick math: fixed overhead plus payroll is about $1404k per month, and contribution margin lands around 56%-67% depending on whether sales commissions and distributor rebates are deducted in the break-even view First-year average revenue is $626k per month, so the model shows break-even in Month 2 with a meaningful cushion What this estimate hides: order volume, pricing mix, quality control rework, and reject rates can move the answer fast
Break-Even Metric Cards
Fixed costs$65.0K
monthly overhead
Contribution margin56%
after variable cost
Break-even revenue$116K/mo
monthly target
Break-even timingMonth 2
model breakeven
Break-Even Calculator
Break-even calculator
Use this calculator to test monthly revenue, variable expenses, and fixed costs against break-even for an extracellular matrix supply business.
Money available to cover fixed costs$1,555,917
$2,213,750 revenue - $657,833 variable expenses
Margin ratio
70%
Covers fixed costs
Yes
Break-even chart Revenue Total costs
Which ECM supply expenses are fixed and which move with released units?
Cost classification
Break-even lands in Month 2 only if fixed commitments and per-unit batch costs stay separated. Treat payroll or quality work as purely variable and the model will overstate early margin.
Expense
Cost
Break-Even Treatment
Common Mistake
GMP facility lease
Fixed
Include in $22,000 monthly overhead from Month 1 through Month 60.
Signing space before order visibility.
Regulatory consulting retainer
Fixed
Include in $12,000 monthly overhead across the full planning period.
Treating it as optional after launch.
Scientific and production payroll
Semi-fixed
Include about $75,400 per month in the first year based on $905,000 annual staffed payroll.
Hiring ahead of batch flow.
Raw tissue and reagents
Variable
Use per-unit inputs by product class; direct unit inputs range from $70 to $680.
Averaging away mix differences.
Sterilization and sterile packaging
Variable
Tie gamma irradiation, sterilization fees, and sterile packaging to released units.
Ignoring failed or reworked lots.
Quality control sampling and third-party testing
Semi-variable
Flex with batch count and release volume, not just booked revenue.
Assuming every lot clears first pass.
Warehousing and cold chain handling
Semi-fixed
Scale lab warehousing, handling labor, and cold chain support in steps as volume rises.
Overbuilding storage before demand proves out.
How does break-even shift from a lean launch to base growth and full scale for an extracellular matrix powder supplier?
Scenario table
Lean break-even is driven by a lighter fixed-cost load, while base and full scale add payroll and quality capacity. Higher batch efficiency and a stronger mix lift margin, but they do not fully erase the overhead step-up.
Planning assumptions only; actual results will move with mix, yield, staffing pace, and pricing.
Scenario
Monthly Revenue
Variable Costs
Fixed Costs
CM Ratio
Operating Profit
Break-Even Signal
Lean launch, Year 1
$626k
$199k
$140k
68%
$287k
Month 2 break-even, so early cash is tight if launch slips.
Base growth, Year 2
$1.33m
$421k
$167k
68%
$745k
Recurring demand gives a stronger cushion, but staffing raises the floor.
Full scale, Year 5
$4.78m
$1.30m
$301k
73%
$3.18m
Best cushion here, but payroll and quality capacity must keep pace.
What breaks the break-even plan if sales slip or costs rise?
Stress test
The plan has a fair cushion, but it gets tight fast if pricing slips or rework rises. At about $626k average monthly Year 1 revenue, $140.4k fixed commitments, and a 56.4% contribution margin, break-even sits near $249k.
Stress Case
Changed Assumption
Break-Even Revenue
Revenue Gap
Risk Signal
Current plan
No change; Year 1 runs at about $626k monthly revenue, $140.4k fixed commitments, and a 56.4% contribution margin.
$249k
$377k cushion
Healthy start, but fixed overhead still needs clean execution.
Revenue shortfall
Sales drop 25% to about $470k while margin stays flat.
$249k
$221k cushion
Demand softens, but the model still clears break-even.
Fixed-cost increase
Monthly commitments rise 15% to about $161.5k.
$286k
$340k cushion
Higher lease, labor, or compliance costs push break-even up.
Margin pressure
Contribution margin falls to 51.4% from unit-input, commission, and rebate pressure.
$273k
$353k cushion
Distributor pricing pressure or QC rework can squeeze the spread.
Combined pressure
Sales fall 25%, fixed commitments rise 15%, and margin drops to 51.4%.
$314k
$156k cushion
Only about $80k operating cushion remains before the plan gets fragile.
Is the ECM supply plan ready to lock the lease and launch team?
Founder checklist
Only lock the lease and full launch team if visible monthly demand can reach the $205K-$249K break-even range, the Year 1 cost stack holds near a 72% contribution margin, and the $933K cash cushion stays intact. If not, stage the build and keep fixed spend light.
1Demand Floor$205K-$249K/mo
Verify monthly orders can reach the break-even band before you sign, because anything below $249K/mo should pause expansion.
2Fixed Load$140.4K/mo
Check the all-in fixed stack of lease, staff, insurance, and software, since that cost lands even if shipments slow.
3Margin Floor72% CM
Confirm Year 1 pricing still leaves about 72% contribution after 17% revenue-linked COGS and 11% selling costs.
4Team Ramp8 FTEs
Do not hire the full Year 1 launch team until the 8-FTE base can run through Month 2 without straining ops.
5Cash Cushion$933K
Hold the minimum cash reserve through the Month 2 trough, or a delay in orders can force a bad cut.
6Launch Gate$1.115M capex
Release equipment spend and first tissue buys only against the $1.115M capex plan and named-buyer or validated research demand, so new capacity does not sit idle.